Using a Community Participatory Research Approach to Understand Satisfaction with Psychopharmacology Among Families of Children with Psychiatric Co-Morbidities
- 100 Downloads
How do parents of children with psychiatric co-morbidities perceive their children’s use of psychiatric medications? To learn more, the Parent/Professional Advocacy League of Massachusetts (PAL), representing families of children with mental health needs, collaborated with researchers on a community-based participatory research (CBPR) study. A questionnaire assessed satisfaction with psychiatric medication as it pertained to children with psychiatric co-morbidities (n = 212). Satisfied parents were likely to employ alternative therapies and feel that prescribers had informed them about medication use and side effects. Results reinforce the need for prescribers to discuss psychopharmacology with families. CBPR improved study relevance and supported PAL’s advocacy efforts.
KeywordsPsychiatric co-morbidities Children Mental health Community-based participatory research Parental satisfaction
We would like to thank the families who made this study possible and the staff at PAL who helped design the survey, recruit participants and interpret the findings. We would also like to thank Dr. Lise Fried for her consultation on the analysis. This study was supported by a grant from the Deborah Munroe Noonan Memorial Fund of Massachusetts.
Conflict of Interest
We have no conflict of interests to report.
- Allen, S. (2007, October 7). Massachusetts tracks children on psychiatric drugs. Prescriptions eyed after overdose. Boston Globe.Google Scholar
- DosReis, S., Butz, A., Lipkin, P., Anixt, J., Weiner, C., & Chernoff, R. (2006). Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community. The Journal of Behavioral Health Services and Research, 423(33), 423–430.CrossRefGoogle Scholar
- Gharabawi, G., Greenspan, A., Rupnow, M., Kosik-Gonzalez, C., Bossie, C., Zhu, Y., et al. (2006). Reduction in psychotic symptoms as a predictor of patients satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial. BMC Psychiatry, 6, 45.CrossRefPubMedGoogle Scholar
- Green, A. R., Ngo-Metzger, Q., Legedza, A. T., Massagli, M. P., Phillips, R. S., & Iezzoni, L. I. (2005). Interpreter services, language concordance, and health care quality. Experiences of Asian Americans with limited English proficiency. Journal of General Internal Medicine, 20(11), 1050–1056.CrossRefPubMedGoogle Scholar
- SAS Institute. (2003). SAS (version 9.2). Cary, NC: SAS Institute, Inc.Google Scholar
- Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. Journal of the American Academy of Child & Adolescent Psychiatry, 38(5), 557–565.CrossRefGoogle Scholar
- Lambert, L., Jerz, M., Friedman, E., & Hacker, K. (2006). Medications and choices. The perspectives of families and youth. Boston, MA: Parent/Professional Advocacy League.Google Scholar
- Minkler, M., & Wallerstein, N. (2003). Introduction to community based participatory research, in community-based participatory research for health. San Francisco, CA: Jossey-Bass.Google Scholar
- Olson, A. L., Kelleher, K. J., Kemper, K. J., Zuckerman, B. S., Hammond, C. S., & Dietrich, A. J. (2001). Primary care pediatricians’ roles and perceived responsibilities in the identification and management of depression in children and adolescents. Ambulatory Pediatrics, 1(2), 91–98.CrossRefPubMedGoogle Scholar
- Shtatland, E., Kleinman, K., & Cain, E. (2004, March 30–April 3). Stepwise methods in using SAS Proc Logistic and SAS Enterprise Miner for Prediction. Paper presented at the Proceedings of the 28th Annual SAS Users Group International Conference, Seattle, WA.Google Scholar
- Stevens, J., Harman, J. S., & Kelleher, K. J. (2005). Sociodemographic and economic comparisons of children prescribed longer-acting versus short-acting stimulant medications for attention deficit hyperactivity disorder. The Journal of Behavioral Health Services and Research, 32(4), 430–437.CrossRefGoogle Scholar
- PAL Membership Survey (2009). Parent Professional Advocacy League. www.ppal.net. Accessed 22 Oct 2006.
- US Food and Drug Administration FDA News. (2004). FDA launches a multi-pronged strategy to strengthen safeguards for children treated with antidepressant medications. http://www.fda.gov/bbs/topics/news/2004/NEW01124.html. Accessed 3 Sept 2007.